Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Thomas, Silverman"'
Autor:
Tarsha Jones, Thomas Silverman, Ashlee Guzman, Julia E. McGuinness, Meghna S. Trivedi, Rita Kukafka, Katherine D. Crew
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background Chemoprevention with anti-estrogens, such as tamoxifen, raloxifene or aromatase inhibitors, have been shown to reduce breast cancer risk in randomized controlled trials; however, uptake among women at high-risk for developing brea
Externí odkaz:
https://doaj.org/article/20718736b05246f3b01af35db5b201b5
Autor:
Vicky Ro, Tarsha Jones, Thomas Silverman, Julia E. McGuinness, Ashlee Guzman, Jacquelyn Amenta, Rita Kukafka, Katherine D. Crew
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background U.S. professional organizations have provided conflicting recommendations on annual vs. biennial mammography screening. Potential harms of more frequent screening include increased anxiety and costs of false positive results, incl
Externí odkaz:
https://doaj.org/article/74df7720657342d0a9420e6d2029bb11
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background Breast cancer chemoprevention can reduce breast cancer incidence in high-risk women; however, chemoprevention is underutilized in the primary care setting. We conducted a pilot study of decision support tools among high-risk women
Externí odkaz:
https://doaj.org/article/4c2ce2db64d2410ea8fb7e3e000e7335
Autor:
Jingwen Zhang, Julia E. McGuinness, Xin He, Tarsha Jones, Thomas Silverman, Ashlee Guzman, Benjamin L. May, Rita Kukafka, Katherine D. Crew
Publikováno v:
American Journal of Preventive Medicine. 64:51-60
In 2009, the U.S. Preventive Services Task Force updated recommended mammography screening frequency from annual to biennial for average-risk women aged 50-74 years. The association between estimated breast cancer risk and mammography screening frequ
Autor:
Katherine D. Crew, Gauri Bhatkhande, Thomas Silverman, Jacquelyn Amenta, Tarsha Jones, Julia E. McGuinness, Jennie Mata, Ashlee Guzman, Ting He, Jill Dimond, Wei-Yann Tsai, Rita Kukafka
Publikováno v:
Cancer Prev Res (Phila)
Significant underutilization of breast cancer chemoprevention remains, despite guidelines stating that physicians should recommend chemoprevention with antiestrogen therapy to high-risk women. We randomized women, ages 35 to 75 years, who met high-ri
Autor:
Rita Kukafka, Samuel Pan, Thomas Silverman, Tianmai Zhang, Wendy K. Chung, Mary Beth Terry, Elaine Fleck, Richard G. Younge, Meghna S. Trivedi, Julia E. McGuinness, Ting He, Jill Dimond, Katherine D. Crew
Publikováno v:
JAMA network open. 5(7)
To promote the identification of women carrying BRCA1/2 variants, the US Preventive Services Task Force recommends that primary care clinicians screen asymptomatic women for an increased risk of carrying a BRCA1/2 variant risk.To examine the effects
Autor:
Thomas Silverman, Jill Dimond, Ting He, Katherine D. Crew, Tarsha Jones, Gauri Bhatkhande, Jennie Mata, Rita Kukafka, Ashlee Guzman
Publikováno v:
Cancer Research. 81:PS8-11
Background: Less than 10 % of those identified as eligible for clinical trials are recruited. Recruitment for chemoprevention trials poses challenges as it is often difficult to identify unaffected patients at high risk for cancer. Barriers to recrui
Publikováno v:
Cancer Research. 81:PS8-35
Background: Chemopreventive agents such as selective estrogen receptor modulators (SERMs; tamoxifen and raloxifene) and aromatase inhibitors (AIs; exemestane and anastrozole) have proven efficacy in reducing breast cancer risk by 41%-79% in high risk
Autor:
Thomas Silverman, Peter A. Shapiro, Tarsha Jones, Katherine Freeman, Marra G. Ackerman, Meghna S. Trivedi, Rita Kukafka, Katherine D. Crew
Publikováno v:
Oncol Nurs Forum
Objectives To examine associations between patient-reported mental illness diagnosis and symptoms and BRCA1/2 genetic testing intention among women undergoing screening mammography. Sample & setting 100 multiethnic women of lower socioeconomic status
Autor:
Jiang X, Tarsha Jones, Meghna S. Trivedi, Rita Kukafka, Wendy K. Chung, Katherine D. Crew, Thomas Silverman, Meghan L. Underhill
Publikováno v:
Journal of Cancer Education
Genetic testing for hereditary breast and ovarian cancer (HBOC) is recommended for breast cancer patients diagnosed at age ≤ 50 years. Our objective was to examine racial/ethnic differences in genetic testing frequency and results among diverse bre